(Bold for FDA approved)
• Blocks alpha 1 adrenergic receptors to reduce noradrenergic hyperactivation
• Stimulation of central noradrenergic receptors during sleep may activate traumatic memories, so blocking this activation may reduce nightmares
• Within a few days to a few weeks
• Dizziness, lightheadedness, headache, fatigue, blurred vision
• Nausea
• Syncope with sudden loss of consciousness
unusual
not usual
• Lower the dose
• Wait
• Wait
• Wait
• In a few weeks, switch to another agent
• 1–16 mg/day, generally in divided doses
• Capsule 1 mg, 2 mg, 5 mg
• Has not been evaluated in controlled studies
• Nightmares may return if prazosin is stopped
• No
• Use with caution in patients with severe impairment
• May require lower dose
• Use with caution
• Use with caution in patients who are predisposed to hypotensive or syncopal episodes
• Some patients may tolerate lower doses better
• Higher risk of orthostatic hypotension and syncope
• Safety and efficacy have not been established
• Effective June 30, 2015, the FDA requires changes to the content and format of pregnancy and lactation information in prescription drug labels, including the elimination of the pregnancy letter categories; the Pregnancy and Lactation Labeling Rule (PLLR or final rule) applies only to prescription drugs and will be phased in gradually for drugs approved on or after June 30, 2001
• Controlled studies have not been conducted in pregnant women
• Prazosin has been used alone or in combination with other hypotensive agents in severe hypertension of pregnancy, with no fetal or neonatal abnormalities reported
• Prazosin should be used during pregnancy only if the potential benefits justify the potential risks to the mother and fetus
• Some drug is present in breast milk
• If child becomes irritable or sedated, breast feeding or drug may need to be discontinued
• Must weigh benefits of breast feeding with risks and benefits of treatment versus nontreatment to both the infant and the mother
Based on data Published online by Cambridge University Press
Compiled by Dr. Jash Ajmera